Arbutus Biopharma Corp (ABUS) — Cash Flow Reinvestment Rate
Arbutus Biopharma Corp (ABUS) has a Cash Flow Reinvestment Rate of 2.91x as of March 2022, reinvesting $60.06 Million (capex $75.00K plus investments $-59.98 Million) from operating cash flow of $20.62 Million. See cash generation quality of Arbutus Biopharma Corp to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Arbutus Biopharma Corp Cash Flow Reinvestment Rate (2012–2012)
Historical reinvestment intensity for Arbutus Biopharma Corp across 1 annual periods. For the full cash flow conversion analysis, see ABUS cash flow conversion.
Annual Cash Flow Reinvestment Rate for Arbutus Biopharma Corp (2012–2012)
Year-by-year capital reinvestment analysis for Arbutus Biopharma Corp. See financial flexibility index of Arbutus Biopharma Corp to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2012 | 0.00x | $14.90K | $33.27 Million | $14.90K | — |